If there is increased complement lability with the underlying kidney disease, as seen with C3G, aHUS, and IgA nephropathy, a progressive decline in kidney function and the associated increase in factor D and FHR1 would promote further complement activation leading to adverse outcomes. Here, LIF is linked to kidney disorder.